摘要
婴幼儿血管瘤(infantile hemangioma,IH)是小儿最常见的良性肿瘤。自2008年以来,普萘洛尔逐渐成为IH的一线治疗药物,但治疗机制尚不完全明了。本文旨在阐述普萘洛尔治疗婴幼儿血管瘤的机制,以便更合理安全地治疗IH。
Infantile hemangioma(IH)is the most common benign tumor in children.Since 2008,propranolol has gradually become the first-line treatment for IH,but the treatment mechanism is not completely understood.This paper aimed to elucidate the mechanism of propranolol in the treatment of IH,so as to provide more reasonable and safe treatment for IH.
作者
宋会新
林春男
王田友
付兆臣
SONG Hui-xin;LIN Chun-nan;WANG Tian-you;FU Zhao-chen(Department of Oral and Maxillofacial Surgery,Second Affiliated Hospital of Harbin Medical University,Harbin 150081,Heilongjiang Province,China)
出处
《中国口腔颌面外科杂志》
CAS
2020年第2期182-185,共4页
China Journal of Oral and Maxillofacial Surgery
关键词
婴幼儿血管瘤
普萘洛尔
治疗机制
Infantile hemangioma
Propranolol
Treatment mechanism
